Symbol="EQRX"
AssetType="Common Stock"
Name="EQRx Inc"
Description="EQRx, Inc., a pharmaceutical company, is engaged in the development of drugs primarily for the treatment of cancer and immuno-inflammatory diseases in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1843762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="C/O CORVEX MANAGEMENT LP, 667 MADISON AVENUE, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1121054000"
EBITDA="-353588000"
PERatio="None"
PEGRatio="None"
BookValue="2.585"
DividendPerShare="0"
DividendYield="0"
EPS="-0.55"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.152"
ReturnOnEquityTTM="-0.193"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2.1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.998"
EVToRevenue="-"
EVToEBITDA="0.281"
Beta="0.626"
num_52WeekHigh="5.71"
num_52WeekLow="1.58"
num_50DayMovingAverage="2.018"
num_200DayMovingAverage="2.243"
SharesOutstanding="487415000"
DividendDate="None"
ExDividendDate="None"
symbol="EQRX"
open="2.26"
high="2.31"
low="2.25"
price="2.30"
volume="1696041.00"
latest_trading_day="2023-08-25"
previous_close="2.26"
change="0.04"
change_percent="1.7699%"
aroon_positive_momentum_days="40"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="3474939"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="511"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0094.jpeg"
image_negative_thumbnail_id_2="169"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="705"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_positive_thumbnail_id_2="625"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0083.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
